UPDATE : Monday, November 18, 2019
상단여백
FDA OKs Boryung's P1 trial for immunotherapy candidate by Lee Han-soo 2019-08-28 14:21
Myongji, SNUH to cooperate on dialysis software by Lee Han-soo 2019-08-28 14:21
Sales of new gastric acid blocker K-Cab top ₩10 billion by Jeong Sae-im 2019-08-28 13:26
Leo Pharma submits IND application for JW Pharmaceutical’s atopy treatment by Lee Han-soo 2019-08-28 13:24
Pharmacists demand audit over Gliatilin’s insurance benefit by Song Soo-youn 2019-08-27 16:01
라인
‘GI Innovation will be small but strong leader of bioindustry’ by Kim Yun-mi 2019-08-27 15:57
Invossa victims, Kolon shareholders demand apology, compensation by Jeong Sae-im 2019-08-27 15:40
HLB to test rivoceranib+Lonsurf in colon cancer by Jeong Sae-im 2019-08-27 15:39
Regulator decides to delist Kolon TissueGene by Jeong Sae-im 2019-08-27 12:15
Possibility proved to use AI in sleep staging classification by Choi Gwang-seok 2019-08-26 17:03
라인
Temple stay beneficial to mental health, SNUH says by Choi Gwang-seok 2019-08-26 15:01
'Myongji Hospital to change concept of sports medicine in Korea’ by Lee Han-soo 2019-08-26 11:43
Pharmaceutical sector’s job growth twice of all industries’ average by Jeong Sae-im 2019-08-26 11:39
Invossa still effective despite mislabeling, maker claims by Lee Han-soo 2019-08-23 20:16
Medipost’s Pneumostem gets FDA’s fast-track designation by Lee Han-soo 2019-08-23 17:51
라인
Vivozon finishes P3 trial for nonnarcotic analgesics by Lee Han-soo 2019-08-23 16:03
49 international healthcare experts receive Korean medical training by Choi Gwang-seok 2019-08-23 16:02
'Surgery more viable option for gastroesophageal reflux disease' by Lee Han-soo 2019-08-23 15:02
HLB wins FDA nod for P2 trial on rivoceranib in adenoid cystic carcinoma by Jeong Sae-im 2019-08-23 15:02
Ministry OKs P1 trial into Haim Bio’s metabolism anticancer drug by Lee Han-soo 2019-08-23 13:53
여백
여백
여백
Back to Top